Adia Nutrition to Trade as Adia Med Inc. After Lightning-Fast FINRA Review

About this update from Adia Nutrition, Inc.

Name change to appear on Daily List today following expedited review; trading begins tomorrow Winter Park, Florida--(Newsfile Corp. - July 9, 2026) - Adia Nutrition, Inc. (OTCQB: ADIA) announced today that FINRA has processed its corporate name change to Adia Med Inc. on an expedited timeline. The name change will be reflected on the FINRA Daily List today, with trading under the new name expected to begin tomorrow, Friday, July 10, 2026, on the OTC Markets. To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/10520/304434_adiamedlogo.jpg The company received confirmation from its transfer agent, Colonial Stock Transfer Company, Inc., following FINRA's review of the corporate action. The swift processing allows the rebrand to take effect faster than initially anticipated. "This name change to Adia Med Inc. better reflects who we are today and where we're headed," said Larry Powalisz, CEO of Adia Med Inc. "As we continue advancing innovative stem cell and regenerative therapies, aligning our corporate name with our mission in healthcare is a natural and important step. We're grateful for the support of Colonial Stock Transfer Company, Inc. and FINRA in making this transition smooth and efficient." Trading under the new name Adia Med Inc. is expected to commence on July 10, 2026. For questions, inquiries, or additional information, please contact Larry Powalisz at [email protected] or by phone at 321-231-2843. About ADIA Med Inc.:Adia Med Inc. (OTCQB: ADIA), based in Winter Park, Florida, is a publicly traded company advancing healthcare through innovation. The company specializes in sales of stem cell and regenerative products, such as AdiaVita and AdiaLink, through its lab division, Adia Labs LLC, which is expanding to include insurance-billable wound care products. Adia is also growing nationwide with Adia Med clinics, specializing in orthopedic, pain management, and wound repair. Adia Med clinics also offer specialized regenerative treatments like stem cell therapies and platelet-rich plasma (PRP), advanced treatments including therapeutic plasma exchange (TPE) and autologous hematopoietic stem cell transplantation (aHSCT), and wound repair services. Revenue is generated through service fees, product sales, equity stakes, and billing insurance for healthcare treatments. Additionally, Adia Med Inc. invests in alig...

View stock analysis, news, and events for Adia Nutrition, Inc.